| Jul 18 |
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
|
| Jul 18 |
Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in MSS Colorectal Cancer
|
| Jul 12 |
IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?
|
| Jun 28 |
Sector Update: Health Care Stocks Edge Higher in Afternoon Trading
|
| Jun 28 |
Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference
|
| Jun 27 |
Cancer Therapy Evaluation Program Announces Availability of Botensilimab for Clinical Studies
|
| Jun 17 |
Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors
|
| Jun 13 |
Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50
|
| Jun 8 |
GSK wins FDA nod to expand label for RSV vaccine
|
| Jun 4 |
Agenus Announces Virtual Annual Shareholders Meeting
|
